Researchers
Podolski-Renić, Ana
Results 1-20 of 189
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | Editorial: Combination therapies in cancer treatment: enhancing efficacy and reducing resistance | Wang, Xinyu; Pešić, Milica | Contribution to periodical | 21aM21a |
| 2025 | Associating Patient Responses with Drug Sensitivity in Non-Small Cell Lung Carcinoma Using an Immunoassay on Patient-Derived Cell Cultures | Podolski-Renić, Ana | Article | 22M22 |
| 2025 | Novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Koračak, Ljiljana; Ajdačić, Vladimir | Article | 21aM21a |
| 2025 | Personalized Genomic Analysis for Clinical Insights in Non-Small Cell Lung Cancer | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2025 | LB-100 Enhances Drugs Efficacy through Inhibition of P-glycoprotien Expression in Multidrug-Resistant Glioblastoma and Non-Small Cell Lung Carcinoma Cellular Models | Podolski-Renić, Ana | Article | 21aM21a |
| 2025 | PARP inhibition increases sensitivity to cisplatin in non-small-cell lung carcinoma via the induction of TET-dependent hydroxymethylation | Grdović, Nevena | Article | 21aM21a |
| 2025 | Two novel pyrimidine-artesunate hybrids overcome multidrug-resistance in non-small cell lung carcinoma through collateral sensitivity | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells | Lupšić, Ema | Article | 21M21 |
| 2025 | Development and Characterization of a Temozolomide-Resistant Human Glioblastoma Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Editorial on Special Issue: “Novel Therapeutic Strategies for Glioblastoma” | Podolski-Renić, Ana | Contribution to periodical | 21aM21a |
| 2025 | Impact of ex vivo cell culturing on ABC transporters' expression and drug sensitivity in patient-derived non-small cell lung cancer models![]() | Dinic, Jelena B | Article | 22M22 |
| 2025 | Adamantane–sclareol hybrids selectively target multidrug resistant glioblastoma cells by inducing oxidative stress | Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2025 | Isorhamnetin Modulates Drug-Resistance-Related Biomarkers in Colon Cancer Cells![]() | Radenković, Nikola; Milenković, Dejan | Article | 21M21 |
| 2025 | Development of a Clinically Relevant Temozolomide-Resistant Human Glioblastoma A-172 Cell Line | Pajović, Milica | Conference Paper | Mp. category will be shown later |
| 2025 | Sclareol-based natural nanoparticles with adamantane moieties exert anticancer effects against non-small cell lung carcinoma cells![]() | Stojković, Pavle | Article | 21aM21a |
| 2024 | Functional diagnostics in non-small cell lung carcinoma - the potential for personalized approach | Lupšić, Ema | Conference Paper | Mp. category will be shown later |
| 2024 | Isolation of extracellular vesicles from resistant tumor cells using nanobodies-based immunoaffinity approach![]() | Filipović, Lidija; Tursunović, Marija | Conference Paper | Mp. category will be shown later |
| 2024 | Integrating functional screening and bioinformatics for personalized medicine approaches in NSCLC | Dragoj, Miodrag | Conference Paper | Mp. category will be shown later |
| 2024 | 3D Glioblastoma Cell Culture within Alginate Microfibers for Long-Term Evaluation of Drug Effects | Jovanović Stojanov, Sofija | Conference Paper | Mp. category will be shown later |
| 2024 | Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine | Dinić, Jelena | Article | 21M21 |
